FDA Releases Guidance on Public Availability of Advisory Committee Members' Financial Interest Information and Waivers

Summary

The Food and Drug Administration (FDA) has issued a guidance document to provide transparency into the financial interests of its advisory committee members and staff, allowing the public to access this information and understand the waiver process that enables participation in advisory committee meetings.